Blood pressure and cationic transport systems during combined calcium channel blocker and calcium administration in males
- PMID: 8803961
Blood pressure and cationic transport systems during combined calcium channel blocker and calcium administration in males
Abstract
A double-blind, placebo-controlled parallel study was conducted on the effects of a high daily oral supplementation of 1 g elemental calcium, given twice daily for 16 weeks, followed by additional administration of 2 mg b.i.d. lacidipine or placebo for 8 weeks, on blood pressure, intracellular cationic concentrations and transport systems, plasma total calcium, ionized calcium and calciotropic hormones in normal male subjects. No significant difference in the effect of lacidipine vs. placebo on standing or recumbent systolic or diastolic blood pressure or heart rate was found between calcium- and placebo-treated subjects. The difference in lacidipine effect on erythrocyte Mg2+ concentration and platelet membrane cholesterol content between the placebo and calcium groups was statistically significant. There was no additional effect between groups of lacidipine on erythrocyte and platelet intracellular Ca2+, Na+ and K+ concentrations or transport systems and on plasma Ca2+ levels and calciotropic hormones. Combined calcium and lacidipine administrations in normal male subjects did not induce antihypertensive effects different from those induced by either agent alone.
Similar articles
-
Dietary calcium, blood pressure and cell membrane cation transport systems in males.J Hypertens. 1995 Aug;13(8):875-82. doi: 10.1097/00004872-199508000-00008. J Hypertens. 1995. PMID: 8557965 Clinical Trial.
-
Erythrocyte and platelet cationic concentrations and transport systems in normal volunteers treated with carmoxirole.Methods Find Exp Clin Pharmacol. 1993 Sep;15(7):483-90. Methods Find Exp Clin Pharmacol. 1993. PMID: 7902890
-
Modification of platelet and lymphocyte calcium handling and blood pressure by dietary sodium and calcium in genetically hypertensive rats.J Lab Clin Med. 1992 Feb;119(2):151-8. J Lab Clin Med. 1992. PMID: 1740628
-
Clinical pharmacology of lacidipine.J Cardiovasc Pharmacol. 1991;17 Suppl 4:S9-13. J Cardiovasc Pharmacol. 1991. PMID: 1726014 Review.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous